Given the potent effects seen clinically with homeostatically-induced lymphocyte activation [60], and the recent findings that T cell homeostatic proliferation appears to be associated with gut flora translocation [61], it may be possible that tumor suppressive activity of IL-2 may be highly dependent on the gut flora, thus possibly explaining inter-patient variation. This evidence concerns the gene IL2 and neoplasm.